NCT03115073View on ClinicalTrials.gov

ProF-001_Phase IIa

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

July 30, 2018

Study Completion Date

July 30, 2018

Conditions
Vulvovaginal Candidiasis (VVC)
Interventions
DRUG

Candiplus

Administration of Candiplus

DRUG

Clotrimazole

Administration of Clotrimazole

Trial Locations (3)

Unknown

Medical University Innsbruck, Innsbruck

Bezirkskrankenhaus Schwaz, Schwaz

Medical University Vienna, Vienna

All Listed Sponsors
lead

ProFem GmbH

INDUSTRY

NCT03115073 - ProF-001_Phase IIa | Biotech Hunter | Biotech Hunter